According to the FDA’s website, “Real-world data (RWD) and real-world evidence (RWE) are playing an increasing role in health care decisions.” How is your organization capitalizing on these vital resources? If your claims and clini…
The Synopsys Cybersecurity Research Center (CyRC) examined data from thousands of commercial software security tests performed in 2020. The CyRC team measured this data against the 2021 OWASP Top 10 list of the most critical security risks to web appli…
Find the best field service management (FSM) software. SelectHub requirements checklists provide you with the top criteria identified by analysts and actual buyers of the software. These practical checklists allow you to save time, limit risk, and redu…
Organizations lose an estimated 5% of their revenue to fraud every year, according to the Association of Certified Fraud Examiners (ACFE). Widespread global disruption caused by the COVID-19 and its aftermath, as well as rising inflation, political ten…
Harnessing a wealth of data to form real-world evidence has amazing potential in the advancement of medical care. But the task of amassing all this data—and analyzing it effectively—can be overwhelming. This Harvard Business Review Analy…
In the United States, prescription drug rebates are a central piece in the overall economic value proposition for medications manufacturers. Drug rebates are complex and the subject of legislative influence, creating a uniquely challenging ecosystem wh…
Sales of sustainably marketed products are growing 2.7 times faster than conventional products. They’re also propelling a third of overall CPG growth, despite their premium pricing in today’s inflationary environment. Get this new report…
Is your pre-IPO organization ready for Sarbanes-Oxley? Amid complex regulatory requirements, accelerating digital transformation, and evolving market, workforce, and workplace dynamics, achieving SOX compliance remains a time- and attention-consuming p…
While other industries have been enjoying the benefits of SaaS LIMS deployments, regulated industries could not. Now, with validated SaaS, those in pharma, biobanking, and other regulated industries can confidently deploy LIMS on a subscription basis a…
In the United States, prescription drug rebates are a central piece in the overall economic value proposition for medications manufacturers. Drug rebates are complex and the subject of legislative influence, creating a uniquely challenging ecosystem wh…
